The printed version of our new paper “Development and persistence of patient-reported visual problems associated with serotonin reuptake inhibiting antidepressants” has just been published. We couldn’t afford open access, so it would normally only be available to purchase or for subscribers of the journal. However, we've paid a fee of $200 USD which allows us to post the … [Read more...] about New Study of Antidepressants and Vision Problems
News
Diagnostic Criteria for Enduring Sexual Dysfunction
Background We noticed that a lack of diagnostic criteria was increasingly being mentioned in the published literature on post-SSRI sexual dysfunction (PSSD). The condition was being described as difficult to diagnose because there was no commonly accepted definition. At the same time, a number of new websites and online discussions were appearing, many of which seemed to … [Read more...] about Diagnostic Criteria for Enduring Sexual Dysfunction
Health Canada warns about Persistent Sexual Dysfunction after SSRIs & SNRIs
Health Canada has just concluded its review of persistent sexual dysfunction after stopping SSRIs and SNRIs. Let’s look at some of the background. January 2019 On 25 January 2019, we were contacted by the Marketed Pharmaceuticals and Medical Devices Bureau at Health Canada. They had become aware of our 2018 paper, “Enduring sexual dysfunction after treatment with … [Read more...] about Health Canada warns about Persistent Sexual Dysfunction after SSRIs & SNRIs
PIMsPlus: Resources for Safer Medications
Today Taper MD launch PIMsPlus.org, a new free searchable resource for safer medication use which is focused on Potentially Inappropriate Medications (PIMs): medications that should be used with caution in older adults because research and clinical experience with these medications have shown that the risk of adverse effects can outweigh the benefits. The aim of … [Read more...] about PIMsPlus: Resources for Safer Medications
PSSD Patient Experiences
New paper "If you wish to have such “syndrome” continue what you are doing ... read obscure studies and reviews in obscure databases and I can guarantee to you that you will have it till the end of your life!" Anyone who has experienced a serious side effect from a medication will know how difficult the conversation with your doctor can be. In our new paper, “Post-SSRI … [Read more...] about PSSD Patient Experiences
EMA Acknowledges Persistent Sexual Dysfunction After SSRIs & SNRIs
The European Medicines Agency has just concluded a review into sexual dysfunction after the discontinuation of SSRIs and SNRIs. Before we discuss their findings, it's worth looking back over the events of the past year. RxISK petition In 2018, we put together a petition requesting changes to SSRI and SNRI product labels to warn about post-SSRI sexual dysfunction (PSSD) and … [Read more...] about EMA Acknowledges Persistent Sexual Dysfunction After SSRIs & SNRIs
Enduring Sexual Dysfunction: 300 Cases
New publications After a great deal of work, we are pleased to announce details of two new publications in the International Journal of Risk & Safety in Medicine. The pre-print versions are currently available. [Now updated with printed versions - June 11, 2018.] The first is our new paper – Enduring sexual dysfunction after treatment with antidepressants, 5α-reductase … [Read more...] about Enduring Sexual Dysfunction: 300 Cases
RxISK 2.0
After months of thought and effort, we are pleased to introduce RxISK 2.0 to replace the website we launched in 2012. Our goal was to make RxISK easier-to-use, friendlier, and to remove the requirement to log in for certain functionality. We freshened up our RxISK logo and tagline and added new tools and resources, such as: Drugs A-Z list Beers criteria for older … [Read more...] about RxISK 2.0
Marketing CoPilot recognized for helping RxISK.org achieve exemplary marketing results in email marketing
TORONTO, ON — April 29, 2014 – Marketing CoPilot® Inc., a leader in Canada for digital marketing strategy and execution, has received the 2013 All Star Award from Constant Contact® Inc., the trusted marketing advisor to more than half a million small organizations worldwide. Each year, Constant Contact bestows the All Star Award to a select group of businesses and … [Read more...] about Marketing CoPilot recognized for helping RxISK.org achieve exemplary marketing results in email marketing
Get Involved with Team RxISK
Team RxISK takes first big step in England: Get involved With millions of people throughout the world participating in sporting events to raise money for many different causes, who would ever think that prescription drug safety could become a cause worth supporting? Katinka Newman did. Katinka Newman As the first fundraiser in the world for Team RxISK Katinka Newman from … [Read more...] about Get Involved with Team RxISK